Towards more Sustainable Peptide- based Antibiotics: Stable in Human Blood, Enzymatically Hydrolyzed in Wastewater?


Journal

Chimia
ISSN: 0009-4293
Titre abrégé: Chimia (Aarau)
Pays: Switzerland
ID NLM: 0373152

Informations de publication

Date de publication:
28 Apr 2021
Historique:
entrez: 27 4 2021
pubmed: 28 4 2021
medline: 29 4 2021
Statut: ppublish

Résumé

The emergence and spread of antibiotic resistance is a major societal challenge and new antibiotics are needed to successfully fight bacterial infections. Because the release of antibiotics into wastewater and downstream environments is expected to contribute to the problem of antibiotic resistance, it would be beneficial to consider the environmental fate of antibiotics in the development of novel antibiotics. In this article, we discuss the possibility of designing peptide-based antibiotics that are stable during treatment (

Identifiants

pubmed: 33902793
doi: 10.2533/chimia.2021.267
doi:

Substances chimiques

Anti-Bacterial Agents 0
Peptides 0
Waste Water 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

267-271

Auteurs

Michael T Zumstein (MT)

Department of Environmental Geosciences, Centre for Microbiology and Environmental Systems Science, University of Vienna, Althanstrasse 14, 1090 Vienna, Austria; Environmental Microbiology Department, Swiss Federal Institute of Aquatic Science and Technology (Eawag), Überlandstrasse 133, CH-8600 Dübendorf, Switzerland; Environmental Chemistry Department, Swiss Federal Institute of Aquatic Science and Technology (Eawag), Überland- strasse 133, CH-8600 Dübendorf, Switzerland;, Email: michael.zumstein@univie.ac.at.

Kathrin Fenner (K)

Environmental Chemistry Department, Swiss Federal Institute of Aquatic Science and Technology (Eawag), Überland- strasse 133, CH-8600 Dübendorf, Switzerland; Department of Chemistry, University of Zurich, CH-8057 Zurich, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH